These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 33331954

  • 21. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Rimantas Lazutka J, Ulys A, Jankevicius F, Jarmalaite S.
    Hum Mol Genet; 2017 Jul 01; 26(13):2451-2461. PubMed ID: 28398479
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.
    He M, Liu Y, Deng X, Qi S, Sun X, Liu G, Liu Y, Liu Y, Zhao M.
    Prostate; 2013 Jul 01; 73(10):1048-56. PubMed ID: 23389960
    [Abstract] [Full Text] [Related]

  • 23. MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia.
    Abramovic I, Vrhovec B, Skara L, Vrtaric A, Nikolac Gabaj N, Kulis T, Stimac G, Ljiljak D, Ruzic B, Kastelan Z, Kruslin B, Bulic-Jakus F, Ulamec M, Katusic-Bojanac A, Sincic N.
    Cancers (Basel); 2021 Apr 25; 13(9):. PubMed ID: 33922968
    [Abstract] [Full Text] [Related]

  • 24. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
    He W, Zhang F, Jiang F, Liu H, Wang G.
    BMC Urol; 2022 Nov 25; 22(1):195. PubMed ID: 36434610
    [Abstract] [Full Text] [Related]

  • 25. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W, Yao G, Zhou K.
    J Cell Biochem; 2019 Aug 25; 120(8):14055-14064. PubMed ID: 30963631
    [Abstract] [Full Text] [Related]

  • 26. The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia.
    Bonnu CH, Ramadhani AN, Saputro RB, Sesotyosari SL, Danarto R, Astuti I, Haryana SM.
    Asian Pac J Cancer Prev; 2021 Mar 01; 22(3):837-842. PubMed ID: 33773548
    [Abstract] [Full Text] [Related]

  • 27. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y, Song C, Yang S.
    Cancer Biother Radiopharm; 2018 Jun 01; 33(5):203-211. PubMed ID: 29916747
    [Abstract] [Full Text] [Related]

  • 28. Importance of miR-20a expression in prostate cancer tissue.
    Pesta M, Klecka J, Kulda V, Topolcan O, Hora M, Eret V, Ludvikova M, Babjuk M, Novak K, Stolz J, Holubec L.
    Anticancer Res; 2010 Sep 01; 30(9):3579-83. PubMed ID: 20944140
    [Abstract] [Full Text] [Related]

  • 29. Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer.
    Damodaran M, Chinambedu Dandapani M, SimonDuraiRaj, SandhyaSundaram, VenkatRamanan S, Ramachandran I, Venkatesan V.
    Mol Biol Rep; 2021 Apr 01; 48(4):3349-3356. PubMed ID: 33948855
    [Abstract] [Full Text] [Related]

  • 30. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
    Xia L, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W, Sha J.
    Biomed Pharmacother; 2020 Apr 01; 124():109863. PubMed ID: 31986411
    [Abstract] [Full Text] [Related]

  • 31. Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia.
    Liu Z, Lin Z, Cao F, Jiang M, Jin S, Cui Y, Niu YN.
    BMC Urol; 2022 Nov 07; 22(1):172. PubMed ID: 36344974
    [Abstract] [Full Text] [Related]

  • 32. MicroRNA-183-5p: A New Potential Marker for Prostate Cancer.
    Waseem M, Ahmad MK, Serajuddin M, Bhaskar V, Sankhwar SN, Mahdi AA.
    Indian J Clin Biochem; 2019 Apr 07; 34(2):207-212. PubMed ID: 31092995
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer.
    Pang C, Song X, Fu C, Zhang Y, Zhang Y, Liu M.
    Clin Lab; 2020 Jan 01; 66(1):. PubMed ID: 32013356
    [Abstract] [Full Text] [Related]

  • 34. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
    Basu S, Majumder S, Bhowal A, Ghosh A, Naskar S, Nandy S, Mukherjee S, Sinha RK, Basu K, Karmakar D, Banerjee S, Sengupta S.
    PLoS One; 2015 Jan 01; 10(5):e0125560. PubMed ID: 25938433
    [Abstract] [Full Text] [Related]

  • 35. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
    Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L.
    Int J Biol Macromol; 2019 May 15; 129():227-232. PubMed ID: 30685303
    [Abstract] [Full Text] [Related]

  • 36. miR-181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation.
    Han Z, Zhan R, Chen S, Deng J, Shi J, Wang W.
    J Cell Biochem; 2020 Feb 15; 121(2):1664-1674. PubMed ID: 31680294
    [Abstract] [Full Text] [Related]

  • 37. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer.
    Pudova EA, Krasnov GS, Nyushko KM, Kobelyatskaya AA, Savvateeva MV, Poloznikov AA, Dolotkazin DR, Klimina KM, Guvatova ZG, Simanovsky SA, Gladysh NS, Tokarev AT, Melnikova NV, Dmitriev AA, Alekseev BY, Kaprin AD, Kiseleva MV, Snezhkina AV, Kudryavtseva AV.
    BMC Med Genomics; 2020 Sep 18; 13(Suppl 8):129. PubMed ID: 32948204
    [Abstract] [Full Text] [Related]

  • 38. Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia.
    Stella M, Russo GI, Leonardi R, Carcò D, Gattuso G, Falzone L, Ferrara C, Caponnetto A, Battaglia R, Libra M, Barbagallo D, Di Pietro C, Pernagallo S, Barbagallo C, Ragusa M.
    Int J Mol Sci; 2024 Sep 19; 25(18):. PubMed ID: 39337566
    [Abstract] [Full Text] [Related]

  • 39. A New Promising Pathway in Aggressive Prostate Cancer: Treg/mir-let8c/lin28b.
    Akalin I, Erol B, Aslan E, Ozkanli SS, Efiloglu O, Yildirim S, Caskurlu T, Yildirim A, Karaman MI.
    Arch Esp Urol; 2022 Jun 19; 75(5):459-466. PubMed ID: 35983819
    [Abstract] [Full Text] [Related]

  • 40. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
    Zeng Y, Kakehi Y, Nouh MA, Tsunemori H, Sugimoto M, Wu XX.
    Prostate; 2009 Feb 15; 69(3):283-92. PubMed ID: 19025891
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.